Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 6 results for "dpco"

10% hike too little, we want more to offset GST impact, say ph...

The pharmaceutical industry has sought permission to increase prices of non-scheduled drugs by more than stipulated 10 per cent in a year as the tax rate on most drugs was increased to 12 per cent under the proposed GST regime from the current incidence of ... Business Standard, 1 week ago

1 images for "dpco"

Times of India, 6 months ago

NPPA finalises format to monitor price of 19 medical devices

Drug price regulator NPPA has finalised a new format to collect data to monitor price movement of 19 medical devices. In a notification, National Pharmaceutical Pricing Authority (NPPA) said it has come out with a new format as reaching a consensus on ...
 Business Standard1 month ago

Sanofi India Q1 net profit dips 27% at Rs 60 cr

Drug firm Sanofi India today reported a 27.36 per cent dip in standalone net profit to Rs 60 crore for the first quarter ended March 31, 2017 on account of price reduction of drugs in the country and lower exports. The company had posted a net profit of Rs ...
 Business Standard1 month ago

NITI Aayog advocates big expenditure hike

A big portion of Centre's total expenditure in the next three years should be on roads and railways where the total spending should rise from Rs 40,000 crore in 2015-16 to over Rs 1.18 lakh crore in 2019-20, the NITI Aayog's three-year action agenda has ...
 Business Standard2 months ago

Medtronic to withdraw latest stents from India after price cap

After Abbott, another major multinational medical devices maker Medtronic has decided to withdraw its latest stents from India following drug price regulator NPPAs move to cap their prices. Besides, Boston Scientific has said it too may follow suit. "We have ...
 Deccan Herald2 months ago

Sanofi to boost volumes, exports as price control hits margins

With price controls continuing to crimp margins, Sanofi India expects a muted growth in the domestic market in 2017 and therefore will be focusing on volumes as well as exports. "We expect to continue to face annualised negative impact of price cuts imposed ...
 DNA2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less